Table 7

Correlation analysis between relative CD8+ T-cell IFN-γ immune responses against TAAs and CMV in HLA-A*02:01+ volunteer blood donors and women in their first pregnancy

HER2/neuMUC1PRAMEWT1
nrnrnrnr
Cross-sectional study group I         
 All donors 107 0.203* 107 0.225* 108 0.168 109 0.149 
 Nulligravidous women 36 0.023 36 0.252 36 0.216 37 0.034 
 Primi-/multiparous women 35 0.180 35 0.045 35 0.016 35 0.078 
 Men 36 0.347* 36 0.292 37 0.205 37 0.305 
Longitudinal study group II         
 First to second trimester 18 −0.015 16 −0.124 17 0.033 19 −0.056 
 1 to 4 d after delivery 19 0.059 16 0.225 16 0.034 21 0.056 
 2 to 3 mo after delivery 17 0.296 16 0.353 17 0.048 22 0.211 
 After completion of nursing 11 −0.309 10 −0.273 11 −0.009 11 0.355 
HER2/neuMUC1PRAMEWT1
nrnrnrnr
Cross-sectional study group I         
 All donors 107 0.203* 107 0.225* 108 0.168 109 0.149 
 Nulligravidous women 36 0.023 36 0.252 36 0.216 37 0.034 
 Primi-/multiparous women 35 0.180 35 0.045 35 0.016 35 0.078 
 Men 36 0.347* 36 0.292 37 0.205 37 0.305 
Longitudinal study group II         
 First to second trimester 18 −0.015 16 −0.124 17 0.033 19 −0.056 
 1 to 4 d after delivery 19 0.059 16 0.225 16 0.034 21 0.056 
 2 to 3 mo after delivery 17 0.296 16 0.353 17 0.048 22 0.211 
 After completion of nursing 11 −0.309 10 −0.273 11 −0.009 11 0.355 

Peptide concentration for stimulation was 10 µmol/L for TAAs and CMV.

r, Spearman’s rank correlation coefficient of relative immune responses; n, number of individuals for whom the correlation between CMV and respective TAA was performed (this number varied, as results for both antigens needed to be available for each individual).

*

P < .05.

or Create an Account

Close Modal
Close Modal